Search Within

Hikmat Al-Ahmadie

  1. "Dean Bajorin"
Formats
  1. Meeting Abstract (96)
  2. Journal Article (51)
  3. Correspondence (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (150)
  2. Department of Pathology and Laboratory Medicine (150)
  3. Genitourinary Oncology Service (150)
  4. Solid Tumor Oncology Division (150)
  5. GSK Faculty (121)
  6. Human Oncology and Pathogenesis Program (121)

More Groups

People
  1. Dean Bajorin (150)
  2. Gopakumar Iyer (126)
  3. David Solit (114)
  4. Jonathan Rosenberg (113)
  5. Bernard Bochner (105)
  6. Michael Berger (72)

More People

Years
  1. 2025 (4)
  2. 2024 (8)
  3. 2023 (6)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. Modern Pathology (17)
  3. Laboratory Investigation (16)
  4. Cancer Research (9)
  5. European Urology (8)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (59)
  2. Nature Publishing Group (22)
  3. American Association for Cancer Research (18)
  4. Nature Research (17)
  5. Elsevier Science, Inc. (11)
  6. Wiley Blackwell (8)

More Publishers

Results (150)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer
    Journal Article

    Iyer, G.; Al-Ahmadie, H.; Schultz, N.; Hanrahan, A. J.; Ostrovnaya, I.; Balar, A. V.; Kim, P. H.; Lin, O.; Weinhold, N.; Sander, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of everolimus in metastatic urothelial cancer
    Journal Article

    Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
    BJU International (2013)

    Fulltext@MSK | Save
  • Recurrent novel and potentially targetable genetic alterations in high grade, invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Kim, P. H.; Sfakianos, J. P.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Bochner, B. H.; Bajorin, D. F.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • Recurrent novel and potentially targetable genetic alterations in high grade, invasive urothelial carcinoma of the bladder
    Meeting Abstract

    Al-Ahmadie, H. A.; Iyer, G.; Kim, P. H.; Sfakianos, J. P.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Bochner, B. H.; Bajorin, D. F.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • E-cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Modern Pathology (2013)

    Fulltext@MSK | Save
  • E-Cadherin (CDH1) is frequently mutated in urothelial carcinoma with signet-ring cell and plasmacytoid morphology
    Meeting Abstract

    Al-Ahmadie, H.; Iyer, G.; Mehra, R.; Chen, Y.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Berger, M. F.; Bajorin, D. F.; Dalbagni, G.; more...
    Laboratory Investigation (2013)

    Fulltext@MSK | Save
  • Defining the genetic basis of everolimus sensitivity in metastatic bladder cancer (MBC) by whole-genome sequencing (WGS)
    Meeting Abstract

    Iyer, G.; Milowsky, M. I.; Al-Ahmadie, H.; Hanrahan, A.; Janakiraman, M.; Heguy, A.; Viale, A.; Socci, N. D.; Sander, C.; Bochner, B.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Al-Ahmadie, H.; Janakiraman, M.; Ostrovnaya, I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Bochner, B.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genome sequencing identifies a basis for everolimus sensitivity
    Journal Article

    Iyer, G.; Hanrahan, A. J.; Milowsky, M. I.; Al-Ahmadie, H.; Scott, S. N.; Janakiraman, M.; Pirun, M.; Sander, C.; Socci, N. D.; Ostrovnaya, I.; more...
    Science (2012)

    Fulltext@MSK | Save
  • Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Meeting Abstract

    Milowsky, M. I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Trout, A.; Flaherty, A.; Gerst, S.; Al-Ahmadie, H.; Ostrovnaya, I.; Bajorin, D. F.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save